Across all practice settings — including inpatient, ambulatory, and community care — nurses can assess, identify, and implement strategies to address patient-related barriers to clinical trial ...

The results of the BARCODE1 trial, published by The New England Journal of Medicine assesses the use of a polygenic risk score in screening for prostate cancer. Prof Michael Inouye, Professor of ...

A noninvasive clinicopathologic and gene expression profiling (CP-GEP)–based tool, the Merlin assay, shows promise for ...

CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ ...

BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...